Xin-Hua Xu: Clinical Trials

6 unknown, 1 completed, 1 recruiting. 8 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	8	Unknown 6, Completed 1, Recruiting 1

Follow Xin-Hua Xu: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy Cadonilimab (AK104) - Non-small Cell Lung Cancer	Phase 2	Recruiting	Xin-Hua Xu	48	2024-03-01	2024-06-21
A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma Sintilimab, Radiotherapy - Oral Cavity Squamous Cell Carcinoma	Phase 2	Unknown	Xin-Hua Xu	70	2023-01-18	2023-03-01
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution. Sintilimab - Hepatocellular Carcinoma	Phase 2	Unknown	Xin-Hua Xu	60	2023-01-12	2023-09-08
Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes Sindillimab - Non-small Cell Lung Cancer	Phase 2	Completed	Xin-Hua Xu	80	2021-12-21	2023-03-31
A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma Nimotuzumab, Docetaxel, Carboplatin - Oral Squamous Cell Carcinoma	Phase 2	Unknown	Xin-Hua Xu	68	2020-06-21	2021-11-08
A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma Sintilimab Combined With Apatinib and Capecitabine - Hepatocellular Carcinoma	Phase 2	Unknown	Xin-Hua Xu	46	2020-06-21	2020-06-24
A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy. Sintilimab, Docetaxel, Pemetrexed - Nonsquamous Non-Small Cell Lung Cancer	Phase 2	Unknown	Xin-Hua Xu	70	2019-03-26	2021-11-08
A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy Sintilimab, Docetaxel, Pemetrexed - Nonsquamous Non-Small Cell Lung Cancer	Phase 2	Unknown	Xin-Hua Xu	76	2019-03-13	2021-11-08

Conditions studied

Carcinoma, Hepatocellular (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)

Interventions

sintilimab (4)  ·  Docetaxel (3)  ·  Pemetrexed (2)  ·  Capecitabine (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Nivolumab (1)  ·  Radiotherapy (1)  ·  apatinib (1)  ·  durvalumab (1)  ·  nimotuzumab (1)  ·  pembrolizumab (1)

Countries

China (8)

Results publications

PMID 36091003